Author:
Barbosa Evora Paulo Roberto,Celotto Andrea Carla,Sumarelli Albuquerque Agnes Afrodite,Martinez Évora Patricia
Publisher
Springer International Publishing
Reference12 articles.
1. Tavares AP, Pimenta Junior AG, Evora PR. [Basis for the therapeutic use of inhaled nitric oxide]. Arq Bras Cardiol. 1995;64(1):45–52.
2. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med. 2000;28(8):2974–8.
3. Allman KG, Young JD, Carapiet D, Stevens JE, Ostman-Smith I, Archer LN. Effects of oxygen and nitric oxide in oxygen on pulmonary arterial pressures of children with congenital cardiac defects. Pediatr Cardiol. 1996;17(4):246–50.
4. Sharma R, Raizada N, Choudhary SK, Bhan A, Kumar P, Juneja R, et al. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension? Indian Heart J. 2001;53(1):48–55.
5. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg. 1995;60(6):1765–71.